Collection of Biological Samples From Patients With Rare Neurological Diseases
ConditionNervous System Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-99
SponsorUniversity Hospital, Toulouse
About this trial
The aim of this project is to improve biological collections of patients presenting rare neurological disorders with known or suspected autoimmune origin. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies.
Eligibility criteria
Qualifiers
all patients with neurological disorders, with known or probable autoimmune involvement. This includes adults and children and peripheral and/or central nervous system symptoms.
Social coverage up to date.
Disqualifiers
Patients with neurological damage from which the autoimmune character can be excluded.
Known anemia and hemoglobin <10 g / dl
Patients under protective supervision (guardianship, curators)
Pregnant or breastfeeding woman
Trial design
Treatments tested in this trial
- Blood collection on admission and longitudinally
Treatment groups
1,000 Participants
are divided into 1 treatment groupLocations
1Purpan University Hospital31059, Toulouse France
Sponsors and collaborators
University Hospital, Toulouse
Lead sponsor
Source ClinicalTrials.gov